PARKINSON’S DISEASE GENE THERAPY CLINICAL TRIAL LAUNCHED IN UK da Admin | Ott 25, 2018 | Clinical“https://labiotech.eu”
PARKINSON’S DISEASE GENE THERAPY CLINICAL TRIAL LAUNCHED IN UK da Admin | Ott 25, 2018 | Clinica“https://labiotech.eu”
PLURISTEM THERAPEUTICS ANNOUNCES FDA ORPHAN DRUG DESIGNATION FOR PLX CELL THERAPY FOR THE TREATMENT OF GRAFT FAILURE AND INCOMPLETE RECOVERY FOLLOWING HEMATOPOIETIC CELL TRANSPLANTATION da Admin | Set 25, 2018 | Regolatorio“https://www.nasdaq.com/”
MESOBLAST HEART FAILURE CELL THERAPY FOR CHILDREN FEATURED AT REGENERATIVE SYMPOSIUM FOR CONGENITAL HEART DISEASE da Admin | Set 25, 2018 | Regulatory“https://www.nasdaq.com”
MESOBLAST HEART FAILURE CELL THERAPY FOR CHILDREN FEATURED AT REGENERATIVE SYMPOSIUM FOR CONGENITAL HEART DISEASE da Admin | Set 25, 2018 | Regolatorio“https://www.nasdaq.com”